Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-05 @ 9:45 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002837
Protocol Section: NCT00002837
Start Identification Module Data
Brief Title: High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
Official Title: Phase I-II Study of Dose Intense Doxorubicin Paclitaxel And Cyclophosphamide With Peripheral Blood Progenitor Cells PBPC And Cytokine Support In Patients With Metastatic Breast Cancer
Acronym: None
Organization: MD Anderson Cancer Center
Organization Class: OTHER
Organization Study ID: DM95-156
Secondary IDs
Secondary ID Type Domain Link
CDR0000065052 REGISTRY NCI PDQ httpsreporternihgovquickSearchP30CA016672
P30CA016672 NIH None None
MDA-DM-95156 OTHER None None
NCI-V96-1017 None None None
Start Status Module Data
Status Verified Date: 2012-07
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: MD Anderson Cancer Center
Lead Sponsor Class: OTHER
Lead Sponsor: MD Anderson Cancer Center
Start Oversight Module Data 256
Description Module: 412
Study Last Update Post Date Type(Status Module):
Attachment: Upload